# Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

> **NCT00622037** · PHASE4 · COMPLETED · sponsor: **Bp Consulting, Inc** · enrollment: 70 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** PEG-400 based artificial tear
- **DRUG:** Systane

## Key facts

- **NCT ID:** NCT00622037
- **Lead sponsor:** Bp Consulting, Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622037, "Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00622037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*